Incannex receives FDA fast track designation for sleep apnea drug
Tweet Send to a Friend
Incannex Healthcare Inc. (NASDAQ: IXHL) announced that the U.S. Food and Drug Administration has granted Fast Track designation for IHL-42X ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


